Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Early Hormone Receptor-positive Breast Cancer × Antineoplastic Agents × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 2 Pancreatic Cancer Resectable 1 Ovarian Carcinosarcoma 1 Noonan Syndrome 5 1 Neoplasms 1 Liver Neoplasms 1 Immune-related Adverse Event 1 Esophageal Neoplasms 1 Early Hormone Receptor-positive Breast Cancer 1 Breast Neoplasms 1 Advanced Solid Tumor 1

Interventions

Antineoplastic Agents 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04278469 2020-02-20

Clinical High and Genomic Low Hormone Receptor-positive Early Breast Cancer Patients With or Without Adjuvant Chemotherapy

Gencurix, Inc.

Phase NA Recruiting

Early Hormone Receptor-positive Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡